BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020

Jan 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-01-07

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-07	Common Stock	M	3000	$21.51	Acquired	330530	Direct
2020-01-07	Common Stock	S	3000	$84.46	Disposed	327530	Direct
2020-01-08	Common Stock	M	4000	$21.51	Acquired	331530	Direct
2020-01-08	Common Stock	S	4000	$84.92	Disposed	327530	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-07	Stock Option (Right to buy Common Stock)	$21.51	M	3000	Disposed	2020-05-11	Common Stock (3000)	Direct
2020-01-08	Stock Option (Right to buy Common Stock)	$21.51	M	4000	Disposed	2020-05-11	Common Stock (4000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	180261	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on June 11, 2019.

F2: Trade made pursuant to a 10b5-1 plan executed on September 6, 2019.

F3: Reflects the number of options outstanding after the transactions from this specific stock option grant.